Pricing Executive Search 

Pricing strategy sits at the center of value, access, and growth. In pharma, biotech, and healthcare, experienced leaders translate evidence into pricing, align payer strategy and contracting, and guide global governance so launches succeed and portfolios perform. 

Klein Hersh connects organizations with pricing and market access executives who build scalable frameworks, lead cross-functional teams, and deliver results across the product lifecycle. 

How Pricing Leadership Drives Results in Pharma, Biotech, and Healthcare 

Pricing executives shape strategy and execution from pre-launch through loss of exclusivity. These are the leaders who:  

  • Develop global pricing strategy, guardrails, and governance 
  • Build launch pricing, indication sequencing, and line extension plans 
  • Integrate HEOR and RWE to support value stories and HTA submissions 
  • Lead U.S. payer strategy, PBM and payer negotiations, and rebate frameworks 
  • Manage international reference pricing, tendering, and country launch sequencing 
  • Partner with commercial, medical, regulatory, and finance to inform forecasts 
  • Establish pricing analytics, dashboards, and price change controls  

These responsibilities call for executives who combine precision and agility while protecting long-term value and keeping access central.

High-Impact Pricing Roles Across the Life Sciences   

TO QUOTE AN EXPERTWe have access to the top talent that Pharma tech and services providers rely on to deliver the solutions and expertise that is the lifeblood of their business model.

We focus on the leadership disciplines that connect clinical evidence to commercial outcomes across life sciences. These domains guide how we target and recruit executive talent.    

  • Global pricing and governance: Policies, playbooks, cross-market coordination, and price change management. 
  • U.S. payer strategy and contracting: PBM negotiations, value-based contracts, channel and specialty pharmacy strategy. 
  • HEOR and RWE for pricing: Value dossiers, HTA readiness, and evidence generation plans that support access to healthcare. 
  • Launch and lifecycle pricing: Indication sequencing, combination pricing, LCM, and loss-of-exclusivity strategies. 
  • International reference pricing and tendering: Country launch order, cluster strategy, and tender excellence. 

Why Leading Life Sciences Organizations Turn to Klein Hersh     

Klein Hersh has defined Precision Executive Search for more than 25 years, delivering visionary leaders shaping the future of life sciences and healthcare. Our team is relationship-centered and industry-focused, with far-reaching networks across pricing, market access, and HEOR. We tailor each search to your portfolio, markets, and operating model.

The result is a clear, disciplined approach that delivers: 

  • Proven leaders across pricing, market access, HEOR, and analytics 
  • A process built on trust, transparent communication, and rigorous evaluation 
  • Alignment to mission, culture, and value creation goals 
  • Consistent delivery of executives who strengthen launch readiness and long-term performance   
TO QUOTE AN EXPERTThe biggest benefits Klein Hersh provided was their speed to hire with qualified candidates. They are highly interactive and on-call as needed. Klein Hersh is simply the best.
David Dornstreich, Quant HC

Pricing Recruiting with Impact   

Progress depends on leaders who link science, value, and access. Klein Hersh connects companies with pricing and market access executives who shape payer strategy, support successful launches, and protect value across the lifecycle. 

Our work reflects the values that define Klein Hersh: precision search, industry immersion, and a commitment to delivering top talent that moves your organization forward. 



Interim Leadership for Pharma Services & Technology Organizations

Services and technology organizations in the pharmaceutical and biotech space often require immediate leadership talent to manage critical projects and maintain operational excellence. Klein Hersh has the expertise to connect these organizations with experienced interim executives who understand both the technical and business aspects of CRO, CDMO, and technology service delivery. Whether you need temporary commercial, finance, operations, HR, or other specific leadership talent, we identify professionals who can seamlessly integrate into your organization and maintain momentum during transitions or growth periods. Our vast talent network includes executives with specific experience in contract research, manufacturing, consulting, and technology services who are ready to step into interim roles.



Delivering Leaders to Power Project Farma’s Onshoring Expansion
Summary: Klein Hersh partnered with Project Farma, a leading engineering services provider supporting the biotech and pharmaceutical industries, to accelerate a large-scale leadership expansion during one of the most pivotal periods in U.S. biomanufacturing. Within months, our team successfully placed seven senior executives, with three outstanding searches underway, helping Project Farma scale its capabilities, deepen client engagement, and strengthen its position as a key driver ...
By Todd Rosengarten
March 12, 2026
Onshoring in Life Sciences: Why the Talent Strategy Will Define the Winners 
Over the past several years, the conversation around onshoring has moved from theory to action. Across the United States, pharmaceutical and biotechnology companies are breaking ground on new manufacturing facilities, expanding domestic supply chains, and rethinking how medicines are produced. From North Carolina to Texas to the Midwest, billions of dollars are being invested in infrastructure designed to bring critical ...
By Todd Rosengarten
May 15, 2026
PharmaVoice Interview: Executive Hiring Changes Reflect a Broader Biotech Comeback 
Read Alexandra Pecci’s article in PharmaVoice: Executive hiring changes reflect a broader biotech comeback. Executive hiring shifts are often indicators of wider trends in the market. Here’s how the hiring landscape for pharma leaders is changing. The biotech market is still in recovery mode, with the number of IPOs gradually rising in the years since 2022’s dismal low. That upward trend is ...
By Jason Hersh
January 30, 2025
Klein Hersh Taps Healthcare Industry Veteran to Elevate Growing Healthcare Recruitment Practice 
March 26, 2025 – Horsham, PA. Klein Hersh, a precision executive search firm specializing in life sciences and healthcare, is pleased to announce the appointment of industry veteran Neil Ravitz as Vice President, Healthcare.   Neil brings 17+ years of executive healthcare leadership experience to Klein Hersh, having driven operational and financial success in some of the nation’s leading healthcare institutions. ...
By Klein Hersh
March 25, 2025